SCHEMBL9998664

SCHEMBL9998664

COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCCCC4)cc3)c2C1)c1ccccc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 19/20 0.86
CDK2 P24941 9/20 0.86
AURKB Q96GD4 8/20 0.86
ABL1 P00519 4/20 0.86
NTRK1 P04629 3/20 0.86
RET P07949 3/20 0.86
FGFR1 P11362 3/20 0.86
LIMK1 P53667 3/20 0.86
BCR P11274 3/20 0.86
PLK4 O00444 2/20 0.86
JAK2 O60674 2/20 0.86
MAP4K4 O95819 2/20 0.86
LCK P06239 2/20 0.86
FYN P06241 2/20 0.86
FES P07332 2/20 0.86
LYN P07948 2/20 0.86
SRC P12931 2/20 0.86
PHKG2 P15735 2/20 0.86
FER P16591 2/20 0.86
MARK3 P27448 2/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1377925 1.00 AURKA (0.86) AURKACDK2AURKBABL1NTRK1
SCHEMBL26184014 0.93 AURKA (0.86) AURKACDK2AURKBABL1NTRK1
SCHEMBL25277403 0.93 AURKA (0.86) AURKACDK2AURKBABL1NTRK1
Danusertib SCHEMBL2685432 0.92 AURKA (1.00) AURKACDK2AURKBABL1NTRK1
Danusertib SCHEMBL466509 0.92 AURKA (1.00) AURKACDK2AURKBABL1NTRK1
SCHEMBL1379851 0.92 AURKA (0.85) AURKACDK2AURKBABL1NTRK1
Danusertib SCHEMBL29453494 0.92 AURKA (0.98) AURKACDK2AURKBABL1NTRK1
SCHEMBL1377947 0.91 AURKA (0.85) AURKACDK2AURKBABL1NTRK1
SCHEMBL3486691 0.91 AURKA (0.85) AURKACDK2AURKBABL1NTRK1
SCHEMBL3486749 0.91 AURKA (0.85) AURKACDK2AURKBABL1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084455-B2 Use of a kinase inhibitor for the treatment of particular resistant tumors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-12-27 US claimed
US-8084455-B2 Use of a kinase inhibitor for the treatment of particular resistant tumors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-12-27 US disclosed